CASHIN RICHARD M JR

10% owner Richard Cashin buys 447.8K shares at $9.91 across 2 transactions, raising stake to 16.31M shares

Richard Cashin, a 10% owner of AdaptHealth Corp., executed 2 separate purchases totaling 447,827 shares for $4,438,927.53 at a blended average price of $9.91 on March 19-20, 2026, increasing his post-transaction holdings to 16,312,698 shares. The current price of $10.37 sits -4.3% below the 52-week high of $10.84, offering a modest premium relative to the $9.91 purchase price but no exceptional valuation context. Cashin's cross-ticker track record shows 2 prior sells with a 90d well-timed rate of 100%, but his prior AHCO trades (3 buys on March 10-12, outcome not yet measurable) provide insufficient evidence of a sustained pattern at this ticker. The company's full-year net income was negative, offsetting otherwise stable quarterly revenue of $820.3M with -0.5% annual growth and a $1.4B market cap, suggesting a mature business without growth momentum.

10% Owner Cashin buys 2,046,691 shares for $19.9M across 3 days at $9.73; holdings jump to 15.86M; cluster buy pattern observed

Richard M. Cashin Jr., a 10% owner, executed 3 separate open-market purchases totaling 2,046,691 shares (2.05M shares) for $19,912,147.84 ($19.9M) over March 10–12, 2026, at a blended average price of $9.73, raising his holdings from 13,818,180 shares to 15,864,871 shares—a net increase of +14.8%. The timing coincides with a 52-week low around $7.33 and a current price of $9.75, placing the blended transaction price within the lower-to-middle portion of the 52-week range ($7.33–$10.84), and the stock is currently down -10.1% from its 52-week high and -8.4% over the trailing 30 days. The acquisition occurs during a period of company headwinds: AdaptHealth is unprofitable on an annual basis despite generating $820.3M in quarterly revenue and $24.5M net income in the latest quarter, with annual revenue growth at -0.5%. A cluster buy pattern—2 other insiders also purchased within the past 14 days—is visible alongside Cashin's purchases. The magnitude of his commitment (a $19.9M outlay increasing his stake by roughly one-seventh) during a downturn period, combined with the simultaneous insider activity, warrants investor attention to the underlying drivers and near-term capital allocation signals.

Titan Director Cashin sells 276,348 shares for $2,855,486.02 (2 sales at $10.31–$10.34), reducing stake by 61.0%

Director Richard M Cashin Jr. executed 2 separate sales totaling 276,348 shares for $2,855,486.02, reducing his holdings from 452,809 shares to 176,461 shares, a 61.0% reduction in his stake at Titan International. The sales occurred at $10.31 and $10.34, just 0.05 below the current price of $10.86 and near the 52-week high. The timing is notable given the stock's strong recent momentum: +49.8% over 30 days and +55.6% over 90 days, placing the current price at the upper bound of the 52-week range. However, context is critical: Cashin retained 176,461 shares post-transaction, maintaining a material shareholding, and the company posted a net loss of $649,000 in its latest quarter while showing only modest 1.3% annual revenue growth, making the fundamental backdrop mixed.